# LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)
> **ANDA206006** · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2016-10-07
## Drug
- **FDA Application Number:** ANDA206006
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)
- **Generic name:** LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN
- **Active ingredients:** AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
- **Dosage form:** CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RISING
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2016-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206006)
---
*MORVS · CC0 1.0*